1887

Abstract

Summary

A large molecular-weight fraction of culture filtrate protected rats and mice against a lethal infection with a heterologous serotype, and to some extent against and The active components were obtained from cultures grown for several days in a simple synthetic medium. Infection and vaccination with serotype 16 induced agglutinating and precipitating antibodies to the components of this serotype only; in rats infected or vaccinated with serotype 1, low titres of agglutinating antibody against type 16 were found. Vaccine prepared from type 1 or 16 increased, within 3 days of infection, the resistance of rats to type-16 organisms; within the same period agglutinins or precipitins were not produced. It is possible that the protection was based on opsonic and antitoxic activities.

Loading

Article metrics loading...

/content/journal/jmm/10.1099/00222615-13-2-201
1980-05-01
2021-10-25
Loading full text...

Full text loading...

/deliver/fulltext/jmm/13/2/medmicro-13-2-201.html?itemId=/content/journal/jmm/10.1099/00222615-13-2-201&mimeType=html&fmt=ahah

References

  1. Altman P. L., Dittman D. S. 1961; Blood and other body fluids. Biological handbook Federation of American Societies for Experimental Biology; Washington, D.C.: p 127
    [Google Scholar]
  2. Bergan T. 1975; In Epidemiological typing of Pseudomonas aeruginosa. edited by Brown M. W. R. Wiley; London: p 189
    [Google Scholar]
  3. Braude A. I., Ziegler E. J., Douglas H., McCutchan J. A. 1977; Antibody to cell wall glycolipid of gram-negative bacteria: induction of immunity to bacteremia and to endotoxemia. J. infect. Dis 136: suppl S167
    [Google Scholar]
  4. Brokopp C. D., Gomez-Lus R., Farmer J. J. 1977; Serological typing of Pseudomonas aeruginosa: use of commercial antisera and live antigens. J. clin. Microbiol 5:640
    [Google Scholar]
  5. Carney S. A., Jones R. J. 1968; Biological and immunochemical properties of culture filtrates of virulent and avirulent strains of Pseudomonas aeruginosa. Br. J. exp. Path 49:395
    [Google Scholar]
  6. Chester I. R., Gray G. W., Wilkinson S. G. 1972; Further studies of the chemical composition of the lipopolysaccharide of Pseudomonas aeruginosa. Biochem. J 126:395
    [Google Scholar]
  7. Evans L. R., Linker A. 1973; Production and characterization of the slime polysaccharide of Pseudomonas aeruginosa. J. Bact 116:915
    [Google Scholar]
  8. Fisher M. W. 1977; A polyvalent human y-globulin immune to Pseudomonas aeruginosa: passive protection of mice against lethal infection. J. infect. Dis suppl 136:S181
    [Google Scholar]
  9. Fisher M. W., Devlin H. B., Gnabasik F. J. 1969; New immunotype schema for Pseudomonas aeruginosa based on protective antigens. J. Bact 98:835
    [Google Scholar]
  10. Habs I. 1957; Untersuchungen fiber die O-antigene von Pseudomonas aeruginosa. Z. Hyg. InfektKrankh 144:218
    [Google Scholar]
  11. Hanessian S., Regan W., Watson D., Haskell T. H. 1971; Isolation and characterization of antigenic components of a new heptavalent Pseudomonas vaccine. Nature (New Biol.) 229:209
    [Google Scholar]
  12. Hoiby N. 1975; Cross-reactions between Pseudomonas aeruginosa and thirty-six other bacterial species. Scand. J. Immun 4: suppl., 2 187
    [Google Scholar]
  13. Hoiby N., Andersen V., Bendixen G. 1975; Pseudomonas aeruginosa infection in cystic fibrosis. Humoral and cellular immune responses against Pseudomonas aeruginosa. Acta path, microbiol. scand (C) 83:459
    [Google Scholar]
  14. Iglewski B. H., Liu P. V., Kabat D. 1977; Mechanism of action of Pseudomonas aeruginosa exotoxin A: adenosine diphosphate-ribosylation of mammalian elongation factor 2 in vitro and in vivo. Infect. Immun 15:138
    [Google Scholar]
  15. Jones R. J. 1968; Protection against Pseudomonas aeruginosa infection by immunisation with fractions of culture filtrates of Ps. aeruginosa. Br. J. exp. Path 49:411
    [Google Scholar]
  16. Jones R. J. 1972; Specificity of early protective responses induced by pseudomonas vaccines. J. Hyg. Camb 70:343
    [Google Scholar]
  17. Jones C. E., Alexander J. W., Fisher M. 1973; Clinical evaluation of Pseudomonas hyperimmune globulin. J. surg. Res 14:87
    [Google Scholar]
  18. Jones R. J., Roe E. A., Gupta J. L. 1978; Low mortality in burned patients in a Pseudomonas vaccine trial. Lancet 2:401
    [Google Scholar]
  19. Klinger J. D., Straus D. C., Hilton C. B., Bass J. A. 1978; Antibodies to proteases and exotoxin A of Pseudomonas aeruginosa in patients with cystic fibrosis: demonstration by radioimmunoassay. J. infect. Dis 138:49
    [Google Scholar]
  20. Kostiala A. A. I. 1977; Radiometric ear index test as a measure of delayed-type hypersensitivity in the rat. Immunology 33:561
    [Google Scholar]
  21. Kostiala A. A. I., McGregor D. D. 1975; The mediator of cellular immunity. IX. The relationship between cellular hypersensitivity and acquired cellular resistance in rats infected with Listeria monocytogenes. J. exp. Med 141:1249
    [Google Scholar]
  22. Leppla S. H. 1976; Large-scale purification and characterization of the exotoxin of Pseudomonas aeruginosa. Infect. Immun 14:1077
    [Google Scholar]
  23. Lieberman M. M. 1978; Pseudomonas ribosomal vaccines: preparation, properties and immunogenicity. Infect. Immun 21:76
    [Google Scholar]
  24. Liu P. V. 1966; The roles of various fractions of Pseudomonas aeruginosa in its pathogenesis. II. Effects of lecithinase and protease. J. infect. Dis 116:112
    [Google Scholar]
  25. Liu P. V., Abe Y., Bates J. L. 1961; The roles of various fractions of Pseudomonas aeruginosa in its pathogenesis. J. infect. Dis 108:218
    [Google Scholar]
  26. McCabe W. R., Bruins S. C., Craven D. E., Johns M. 1977; Cross-reactive antigens: their potential for immunization-induced immunity to gram-negative bacteria. J. infect. Dis 136: suppl S161
    [Google Scholar]
  27. McGregor D. D., Kostiala A. A. I. 1976; The role of lymphocytes in cellular resistance to infection. Contemp. Top. Immunobiol 5:237
    [Google Scholar]
  28. Michaels G. B., Eagon R. G. 1966; The effect of ethylenediamine-tetra acetate and of lysozyme on isolated lipopolysaccharide from Pseudomonas aeruginosa. Proc. Soc. exp. Biol. Med 122:866
    [Google Scholar]
  29. Miler J. M., Spilsbury J. F., Jones R. J., Roe E. A., Lowbury E. J. L. 1977; A new polyvalent Pseudomonas vaccine. J. med. Microbiol 10:19
    [Google Scholar]
  30. Morihara K. 1963; Pseudomonas aeruginosa proteinase. I. Purification and general properties. Biochim. biophys. Acta 73:113
    [Google Scholar]
  31. Munster A. M., Leary A. G. 1977; Cell-mediated immune responses to Pseudomonas aeruginosa. Am. J. Surg 133:710
    [Google Scholar]
  32. Pavlovskis O. R., Voelker F. A., Shackelford A. H. 1976; Pseudomonas aeruginosa exotoxin in mice: histopathology and serum enzyme changes. J. infect. Dis 133:253
    [Google Scholar]
  33. Pollack M., Anderson S. E. Jr 1978; Toxicity of Pseudomonas aeruginosa exotoxin A for human macrophages. Infect. Immun 19:1092
    [Google Scholar]
  34. Pollack M., Taylor N. S., Callahan L. T. 1977; Exotoxin production by clinical isolates of Pseudomonas aeruginosa. Infect. Immun 15:776
    [Google Scholar]
  35. Reed L. J., Muench H. 1938; A simple method of estimating fifty per cent endpoints. Am. J. Hyg 27:493
    [Google Scholar]
  36. Sadoff J. C., Artenstein M. S. 1974; The outer cell-wall membrane of Pseudomonas aeruginosa. J. infect. Dis 130: suppl S81
    [Google Scholar]
  37. Saelinger C. B., Snell K., Holder I. A. 1977; Experimental studies on the pathogenesis of infections due to Pseudomonas aeruginosa: direct evidence for toxin production during pseudomonas infection of burned skin tissues. J. infect. Dis 136:555
    [Google Scholar]
  38. Sensakovic J. W., Bartell P. F. 1974; The slime of Pseudomonas aeruginosa: biological characterization and possible role in experimental infection. J. infect. Dis 129:101
    [Google Scholar]
  39. Snell K., Holder I. A., Leppla S. A., Saelinger C. B. 1978; Role of exotoxin and protease as possible virulence factors in experimental infections with Pseudomonas aeruginosa. Infect. Immun 19:839
    [Google Scholar]
  40. Stieritz D. D., Holder I. A. 1978; Experimental studies of the pathogenesis of Pseudomonas aeruginosa infection: evidence for the in-vivo production of a lethal toxin. J. med. Microbiol 11:101
    [Google Scholar]
  41. Verder E., Evans J. 1961; A proposed antigenic schema for the identification of strains of Pseudomonas aeruginosa. J. infect. Dis 109:183
    [Google Scholar]
  42. Vymola F., Lochmann O. 1974; Characteristics of Pseudomonas haemolysin. J. Hyg. Epidem. Microbiol. Immun 18:302
    [Google Scholar]
  43. Young L. S., Yu B. H., Armstrong D. 1970; Agar-gel precipitating antibody in Pseudomonas aeruginosa infections. Infect. Immun 2:495
    [Google Scholar]
  44. Young V. M., Moody M. R. 1974; Serotyping of Pseudomonas aeruginosa. J. infect. Dis suppl 130:S47
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jmm/10.1099/00222615-13-2-201
Loading
/content/journal/jmm/10.1099/00222615-13-2-201
Loading

Data & Media loading...

Most cited this month Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error